Ropes & Gray Advises Underwriters in Biohaven Ltd.’s $287.5 Million Follow-On Offering

In The News
October 2, 2024

Ropes & Gray represented the underwriters in Biohaven Ltd.’s $287.5 million follow-on offering of 6,052,631common shares at $47.50 per share. The transaction closed on Oct. 2 and was announced in a press release.

Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases.

The deal team was led by capital markets partner Will Michener, IP transactions partner Melissa Rones and life sciences regulatory & compliance partner Kellie Combs.